Skip to content
Search

Latest Stories

Thalaivi: Ahead of the trailer launch, Kangana Ranaut shares a few stills from the film, showcases her transformation

By Murtuza Iqbal

Kangana Ranaut celebrates her birthday on 23rd March, and on this occasion, the makers of her next film Thalaivi have decided to launch the trailer of the film. It will be launched at two events, one in Mumbai and another one in Chennai.


Ahead of the trailer launch, today, Kangana took to Twitter to share a few stills from the film and showcased her transformation. She tweeted, “One day to go for the trailer launch of #Thalaivi Gaining 20 kgs and loosing it all back within a span of few months wasn’t the only challenge that I faced while filming this Epic Biopic, wait is getting over just in few hours Jaya will be your forever.”

Directed by AL Vijay, Thalaivi is a biopic on late actress-turned-politician Jayalalithaa. Shot in Tamil, Telugu, and Hindi, the trilingual film also stars Arvind Swami, Bhagyashree, and Madhoo. It is slated to release on 23rd April 2021.

Talking about other films of Kangana, the actress has Dhaakad, Manikarnika Returns: The Legend of Didda, and Tejas in her kitty. The actress is currently busy with the shooting of Tejas and has wrapped up a schedule for Dhaakad.

Dhaakad is slated to release on 1st October 2021, and Manikarnika Returns: The Legend of Didda will start rolling in 2022.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less